Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Renal tubule insulin receptor modestly promotes elevated blood pressure and markedly stimulates glucose reabsorption
Jonathan M. Nizar, Blythe D. Shepard, Vianna T. Vo, Vivek Bhalla
Jonathan M. Nizar, Blythe D. Shepard, Vianna T. Vo, Vivek Bhalla
View: Text | PDF
Research Article Endocrinology Nephrology

Renal tubule insulin receptor modestly promotes elevated blood pressure and markedly stimulates glucose reabsorption

  • Text
  • PDF
Abstract

Although the cause of hypertension among individuals with obesity and insulin resistance is unknown, increased plasma insulin, acting in the kidney to increase sodium reabsorption, has been proposed as a potential mechanism. Insulin may also stimulate glucose uptake, but the contributions of tubular insulin signaling to sodium or glucose transport in the setting of insulin resistance is unknown. To directly study the role of insulin signaling in the kidney, we generated inducible renal tubule–specific insulin receptor–KO mice and used high-fat feeding and mineralocorticoids to model obesity and insulin resistance. Insulin receptor deletion did not alter blood pressure or sodium excretion in mice on a high-fat diet alone, but it mildly attenuated the increase in blood pressure with mineralocorticoid supplementation. Under these conditions, KO mice developed profound glucosuria. Insulin receptor deletion significantly reduced SGLT2 expression and increased urinary glucose excretion and urine flow. These data demonstrate a direct role for insulin receptor–stimulated sodium and glucose transport and a functional interaction of insulin signaling with mineralocorticoids in vivo. These studies uncover a potential mechanistic link between preserved insulin sensitivity and renal glucose handling in obesity and insulin resistance.

Authors

Jonathan M. Nizar, Blythe D. Shepard, Vianna T. Vo, Vivek Bhalla

×

Figure 3

Effect of Fludrocortisone on high-fat–fed control and iTIRKO mice.

Options: View larger image (or click on image) Download as PowerPoint
Effect of Fludrocortisone on high-fat–fed control and iTIRKO mice.
(A) E...
(A) Experimental scheme. After high-fat feeding and doxycycline administration to induce Cre expression, we collected urine from control (black, n = 11) and iTIRKO (red, n = 9) mice fed vehicle followed by fludrocortisone. Blue line denotes interval with daily urine collection. (B and C) Daily water intake (B) and urine output (C) of high-sodium– and high-fat–fed control and iTIRKO mice. (D) Urinary glucose excretion on vehicle and on the fourth day of fludrocortisone. (E) Glucose tolerance test tracing before (circles, n = 11, control; 5, iTIRKO) and after (squares, n = 11, control; 5, iTIRKO) treatment with fludrocortisone (squares), and (F) calculated AUC. (G) Creatinine clearance on fourth day of fludrocortisone (control, n = 6; iTIRKO, n = 6) and separate mice on the same diet without fludrocortisone (control, n = 6; iTIRKO, n = 6). Control represents age-matched littermates of iTIRKO mice. iTIRKO, inducible renal tubular insulin receptor–KO mice; w, week; d, day; IPGTT, i.p. glucose tolerance test. *P < 0.05 by 2-tailed t test compared with control mice (C and D). *P < 0.05 by 2-way ANOVA with Tukey correction for multiple comparisons (D and F). #P < 0.05 for effect of fludrocortisone independent of genotype by 2-way ANOVA. In box and whisker plots, the whiskers represent minimum and maximum values, and box borders represent the 25th percentile, median, and 75th percentile.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts